05/09/2024
8:05 AM | BioXcel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:12 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
5:01 AM | BioXcel Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
5:03 AM | BioXcel Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024
6:10 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
6:01 AM | BioXcel Therapeutics (Filer)
| Form PRE 14A | |
04/10/2024
6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/08/2024
6:30 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:31 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:32 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:32 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:32 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
6:30 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
1:50 PM | BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
1:01 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
12:20 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
12:40 PM | BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
3:55 PM | BioXcel Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/25/2024
3:05 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
6:15 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
11:45 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
7:35 AM | BioXcel Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/08/2024
4:27 PM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
02/08/2024
6:08 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
6:27 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
BioXcel Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024
11:15 PM | BioXcel Therapeutics (Filer)
| Form EFFECT | |
12/18/2023
3:52 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:54 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:55 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:57 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:47 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
6:22 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
11:15 PM | BioXcel Therapeutics (Filer)
| Form EFFECT | |
11/13/2023
10:59 AM | BioXcel Therapeutics (Filer)
| Form RW WD | |
11/13/2023
9:23 AM | BioXcel Therapeutics (Filer)
| Form RW | |
11/02/2023
5:01 AM | BioXcel Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/19/2023
3:48 PM | BioXcel Holdings, Inc. (Filed by)
BioXcel Therapeutics (Subject)
| Form SC 13G/A | |
10/13/2023
3:01 PM | BioXcel Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
I’m afraid WWIII is a very real possibility (Ad) As one top U.S. cyber official claims: This [tech] is “the most powerful weapon of our time.”
That's also why I've produced this new film. Take a look. |
10/10/2023
8:09 AM | BioXcel Therapeutics (Subject)
FIL Ltd (Filed by)
| Form SC 13G/A | |
10/10/2023
6:06 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
4:07 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2023
10:21 AM | BioXcel Therapeutics (Subject)
Mueller Family 2010 Irrevocable Trust (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023
9:55 AM | BioXcel Therapeutics (Subject)
MUELLER PETER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023
10:15 AM | BioXcel Therapeutics (Subject)
Peter Mueller 2018 Irrevocable Family Trust (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2023
7:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
3:47 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:47 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:48 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:49 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:49 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2023
6:01 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
8:11 AM | BioXcel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
6:20 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
3:17 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
5:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
3:58 PM | BioXcel Therapeutics (Issuer)
Laumas Sandeep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
3:59 PM | BioXcel Therapeutics (Issuer)
MILLER MICHAEL PATRICK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
4:01 PM | BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
4:02 PM | BioXcel Therapeutics (Issuer)
Bray June (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
11:28 AM | BioXcel Therapeutics (Subject)
Mueller Family 2010 Irrevocable Trust (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023
11:20 AM | BioXcel Therapeutics (Subject)
Peter Mueller 2018 Irrevocable Family Trust (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023
11:05 AM | BioXcel Therapeutics (Subject)
MUELLER PETER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
5:42 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
5:44 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
5:46 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
5:36 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
5:40 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
1:13 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2023
3:37 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
2:26 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
